Aqtual
PrivateLast Round
Series B
Jul 10, 2025
Total Funding Raised
$47M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aqtual operates in Healthcare & Life Sciences and is based in Hayward, California. Its latest recorded funding round was a Series B round in July 2025.
Aqtual is a biotechnology company that develops precision medicine products for chronic disease management and oncology using a novel cell-free DNA-based platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aqtual Comparables
Compare Aqtual with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precede | 85% | |
| Adela | 83% | |
| Scipher Medicine | 81% |
For institutional investors. Book with your work email.
Aqtual Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 10, 2025 | ||||
| Series A | Oct 31, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Aqtual Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Genoa Ventures | Series B, Series A |
| BOLD Capital Partners | Series B |
| Manta Ray Ventures | Series B, Series A |
| Yu Galaxy | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 112% MoM, reaching 5.4K.
- Jul 26, 2026
Monthly visitors increased 54% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
Aqtual Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Aqtual's valuation, stock price, and market status.
Is Aqtual a public or private company?
Aqtual is a private company.
What is the current stock price of Aqtual?
Aqtual is a private company, so its shares have no public market price. Caplight tracks Aqtual's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Aqtual worth (valuation)?
Valuation information for Aqtual is not publicly available.
Can I buy Aqtual stock?
Aqtual shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Aqtual's last funding round?
Aqtual's most recent funding round was Series B on July 10, 2025.
Who are the main investors in Aqtual?
Key investors in Aqtual include Genoa Ventures, Manta Ray Ventures, Yu Galaxy.
Will Aqtual IPO soon?
No public IPO plans have been announced for Aqtual.
How can I track Aqtual secondary market activity?
Caplight tracks bids, offers, and trades in Aqtual's shares on secondary markets.